Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03HBZ
|
||||
Former ID |
DNC012028
|
||||
Drug Name |
(3-Ethyl-indol-1-yl)-propyl-pyridin-4-yl-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [534087] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H21N3
|
||||
Canonical SMILES |
CCCN(C1=CC=NC=C1)N2C=C(C3=CC=CC=C32)CC
|
||||
InChI |
1S/C18H21N3/c1-3-13-20(16-9-11-19-12-10-16)21-14-15(4-2)17-7-5-6-8-18(17)21/h5-12,14H,3-4,13H2,1-2H3
|
||||
InChIKey |
KHGNFQVPPCBUSI-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Alpha-2C adrenergic receptor | Target Info | Inhibitor | [534087] | |
Alpha-2B adrenergic receptor | Target Info | Inhibitor | [534087] | ||
Alpha-2A adrenergic receptor | Target Info | Inhibitor | [534087] | ||
Reactome | Adrenoceptors | ||||
Adrenaline signalling through Alpha-2 adrenergic receptor | |||||
Adrenaline,noradrenaline inhibits insulin secretion | |||||
G alpha (i) signalling events | |||||
G alpha (z) signalling events | |||||
Surfactant metabolismR-HSA-390696:Adrenoceptors | |||||
G alpha (z) signalling eventsR-HSA-390696:Adrenoceptors | |||||
Surfactant metabolism | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.